Shanghai Ark Biopharmaceutical Co., Ltd.

Works in Cardiovascular · Infectious disease · Psychiatry · Respiratory

Shanghai Ark Biopharmaceutical Co., Ltd. is a clinical trial sponsor. It has 3 active clinical trials with 585 planned participants, in Cardiovascular, Infectious disease, Psychiatry and Respiratory. Since 2021 it has completed 12 trials and stopped 1 early.

Trial track record · since 2021

3Active trials585 planned participants
12Completed0 with results posted
1Stopped early8% of finished trials

Pipeline · 3 active trials

StageTrialStatus

Questions about Shanghai Ark Biopharmaceutical Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-29.

Approve Suite is not affiliated with Shanghai Ark Biopharmaceutical Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.